Due to the time or budget constraints, process development is often underestimated at the early development phases, slowing down and jeopardizing high-value projects. At SpiroChem, thanks to our in-depth understanding of drug development challenges, we recommend and offer Early Route Scouting that guarantees smoother, safer, faster and more cost-effective scale-up from pre-clinical studies, paving the way for clinical development and market.
The MedChem route:
The short-term benefits:
The earlier a robust route is designed and developed, the shorter the overall time and the lesser the investments until process validation and registration.
SpiroChem helps you to be prepared to ensure: